DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹9,360 Cr | ₹7,845 Cr | ₹7,767 Cr | ₹8,960 Cr | ₹6,969 Cr |
What is the latest Revenue of DIVIS LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹9,360 Cr |
| Mar2024 | ₹7,845 Cr |
| Mar2023 | ₹7,767 Cr |
| Mar2022 | ₹8,960 Cr |
| Mar2021 | ₹6,969 Cr |
How is Revenue of DIVIS LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,360 Cr | 19.31 | |
| Mar2024 | ₹7,845 Cr | 1.00 | |
| Mar2023 | ₹7,767 Cr | -13.31 | |
| Mar2022 | ₹8,960 Cr | 28.56 | |
| Mar2021 | ₹6,969 Cr | - | |
Compare Revenue of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹180,140.4 Cr | 1.1% | -1.1% | 0.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,104.0 Cr | 3.5% | -1.5% | 9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,871.0 Cr | -0.2% | -0.3% | 35% | Stock Analytics | |
| CIPLA | ₹114,334.0 Cr | 3.1% | 1% | -11.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,761.0 Cr | 1.1% | -2.1% | -5.6% | Stock Analytics | |
| MANKIND PHARMA | ₹104,779.0 Cr | 7.7% | 0.9% | 2.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.1% |
-1.1% |
0.8% |
| SENSEX | 1.1% |
2.4% |
-5% |
You may also like the below Video Courses